DE07725949T1 - Monoklonale anti-annexin-a3-antikörper zum nachweis von prostatakrebs - Google Patents

Monoklonale anti-annexin-a3-antikörper zum nachweis von prostatakrebs Download PDF

Info

Publication number
DE07725949T1
DE07725949T1 DE07725949T DE07725949T DE07725949T1 DE 07725949 T1 DE07725949 T1 DE 07725949T1 DE 07725949 T DE07725949 T DE 07725949T DE 07725949 T DE07725949 T DE 07725949T DE 07725949 T1 DE07725949 T1 DE 07725949T1
Authority
DE
Germany
Prior art keywords
antibody
annexin
tgc
seq
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE07725949T
Other languages
German (de)
English (en)
Inventor
André SCHRATTENHOLZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProteoSys AG
Original Assignee
ProteoSys AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProteoSys AG filed Critical ProteoSys AG
Publication of DE07725949T1 publication Critical patent/DE07725949T1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE07725949T 2006-06-09 2007-06-11 Monoklonale anti-annexin-a3-antikörper zum nachweis von prostatakrebs Pending DE07725949T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US81208906P 2006-06-09 2006-06-09
US812089P 2006-06-09
US85948906P 2006-11-17 2006-11-17
US859489P 2006-11-17
PCT/EP2007/005134 WO2007141043A2 (en) 2006-06-09 2007-06-11 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma

Publications (1)

Publication Number Publication Date
DE07725949T1 true DE07725949T1 (de) 2009-07-02

Family

ID=38653814

Family Applications (1)

Application Number Title Priority Date Filing Date
DE07725949T Pending DE07725949T1 (de) 2006-06-09 2007-06-11 Monoklonale anti-annexin-a3-antikörper zum nachweis von prostatakrebs

Country Status (13)

Country Link
US (1) US8012697B2 (https=)
EP (1) EP2024748B1 (https=)
JP (1) JP2009540278A (https=)
KR (1) KR20090023372A (https=)
AU (1) AU2007256377B2 (https=)
CA (1) CA2654330A1 (https=)
DE (1) DE07725949T1 (https=)
DK (1) DK2024748T3 (https=)
ES (1) ES2396730T3 (https=)
PL (1) PL2024748T3 (https=)
PT (1) PT2024748E (https=)
RU (1) RU2467335C2 (https=)
WO (1) WO2007141043A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
EP2344544A2 (en) * 2008-09-26 2011-07-20 ProteoSys AG Novel antibodies recognizing native annexin a3
FR2968767B1 (fr) 2010-12-08 2012-12-21 Biomerieux Sa Procede et coffret pour le diagnostic in vitro du cancer de la prostate
WO2013076222A1 (en) 2011-11-23 2013-05-30 Proteosys Ag Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer
FR2991777B1 (fr) 2012-06-07 2015-08-21 Biomerieux Sa Procede de detection et/ou de dosage de l'annexine a3 d'un mammifere dans le sang ou au moins un de ses derives
WO2015035941A1 (en) * 2013-09-12 2015-03-19 The University Of Hong Kong Use of annexin a3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
US9470677B2 (en) 2013-11-28 2016-10-18 Samsung Electronics Co., Ltd. Cell with surface coated with ANXA1 and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104910C3 (de) 1991-02-18 2000-02-24 Schloemann Siemag Ag Stahlnachbehandlungsanlage
US5136855A (en) 1991-03-05 1992-08-11 Ontario Hydro Heat pump having an accumulator with refrigerant level sensor
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
DE10217254A1 (de) 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
JP5068543B2 (ja) * 2004-02-16 2012-11-07 プロテオジス アクチェンゲゼルシャフト がんに関する診断マーカー
EP1724585A1 (en) * 2005-05-21 2006-11-22 ProteoSys AG Annexin for cancer risk assessment
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment

Also Published As

Publication number Publication date
US8012697B2 (en) 2011-09-06
EP2024748A2 (en) 2009-02-18
KR20090023372A (ko) 2009-03-04
AU2007256377B2 (en) 2012-11-01
WO2007141043A2 (en) 2007-12-13
RU2008152009A (ru) 2010-07-20
ES2396730T3 (es) 2013-02-25
AU2007256377A1 (en) 2007-12-13
CA2654330A1 (en) 2007-12-13
JP2009540278A (ja) 2009-11-19
RU2467335C2 (ru) 2012-11-20
EP2024748B1 (en) 2012-12-12
DK2024748T3 (da) 2013-03-18
WO2007141043A3 (en) 2008-03-20
PL2024748T3 (pl) 2013-05-31
PT2024748E (pt) 2013-01-16
US20100233160A1 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
AU2019202676B2 (en) Antigen binding constructs to CD8
DE07725949T1 (de) Monoklonale anti-annexin-a3-antikörper zum nachweis von prostatakrebs
DE69922261T2 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
CN105111308B (zh) 抗N3pGlu淀粉样蛋白BETA肽抗体及其用途
DE69532940T2 (de) Verfahren zur Herstellung modifizierter Immunoglobuline mit verminderter Immunogenität der variablen Domänen eines Antikörpers der Maus, Zusammensetzungen, die diese enthalten
CH701730B1 (de) VCAM-1 spezifischer monoklonaler Antikörper.
DE69622385T2 (de) Verbindungen und verfahren zum nachweis von t. cruzi-infektion
DE69431602T2 (de) Monoklonale antikörper zur diagnose und behandlung von kolorektalkrebs
AT500800B1 (de) Verfahren zur bestimmung von probnp
WO2015016267A1 (ja) 抗ヒトｃｄ２６モノクローナル抗体又はその抗原結合性断片
US20130195761A1 (en) Compositions comprising anti-cap37 antibodies and methods of production and use thereof
CN102971343A (zh) 用于癌症诊断和/或预后的新型抗体
EP2386577A3 (en) Tumor-targeting monoclonal antibodies to FZD10 and uses thereof
ES2747920T3 (es) Anticuerpo anti-NKP46 para diagnóstico de un linfoma de células T periféricas no cutáneo (PTCL)
EP3954999B1 (en) Compositions and methods for detecting and treating ovarian cancer
AU2021226178A1 (en) Multiplex immunofluorescence detection of target antigens
DE102014000857A1 (de) Hybridom-Zelllinie (My-C-cC0C2-235-3H8) und deren Verwendung zur Herstellung eines monoklonalen Antikörpers gegen das humane, herzspezifische Myosin Binding Protein C (C-protein, MYBPC3, cMyBP-C oder My-C)
JP2009540278A5 (https=)
EP1173765B1 (de) Diagnostischer und therapeutischer einsatz von antikörpern gegen den urokinase-rezeptor
EP0460190A1 (de) Verfahren zum nachweis von malignen erkrankungen.
DE60219645T2 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
DE60132221T2 (de) Reagenzien zur zellselektion und verfahren zur anwendung
DE60029953T2 (de) Spezifische Antikörper gegen humanes Choriongonadotropin und deren Verwendung in Therapie und Diagnose
TW202546008A (zh) Her2標靶藥物
CN112239505A (zh) 重组抗cd171八价抗体及神经来源外泌体的捕获方法